NL7006158A - - Google Patents

Info

Publication number
NL7006158A
NL7006158A NL7006158A NL7006158A NL7006158A NL 7006158 A NL7006158 A NL 7006158A NL 7006158 A NL7006158 A NL 7006158A NL 7006158 A NL7006158 A NL 7006158A NL 7006158 A NL7006158 A NL 7006158A
Authority
NL
Netherlands
Application number
NL7006158A
Other versions
NL166937C (nl
NL166937B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7006158A publication Critical patent/NL7006158A/xx
Publication of NL166937B publication Critical patent/NL166937B/xx
Application granted granted Critical
Publication of NL166937C publication Critical patent/NL166937C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL7006158.A 1969-04-29 1970-04-28 Werkwijze voor de bereiding van een farmacologisch werkzame 2-(dialkoxyfenoxy)ethylamineverbinding, als- mede gedoseerd farmaceutisch preparaat. NL166937C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB21889/69A GB1262785A (en) 1969-04-29 1969-04-29 Improvements in or relating to phloroglucinol derivatives

Publications (3)

Publication Number Publication Date
NL7006158A true NL7006158A (en:Method) 1970-11-02
NL166937B NL166937B (nl) 1981-05-15
NL166937C NL166937C (nl) 1981-10-15

Family

ID=10170510

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7006158.A NL166937C (nl) 1969-04-29 1970-04-28 Werkwijze voor de bereiding van een farmacologisch werkzame 2-(dialkoxyfenoxy)ethylamineverbinding, als- mede gedoseerd farmaceutisch preparaat.

Country Status (8)

Country Link
US (1) US3740397A (en:Method)
JP (1) JPS5136256B1 (en:Method)
BE (1) BE749079A (en:Method)
CH (1) CH508585A (en:Method)
DE (1) DE2020464A1 (en:Method)
FR (1) FR2042382B1 (en:Method)
GB (1) GB1262785A (en:Method)
NL (1) NL166937C (en:Method)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2131893A2 (en) * 1971-04-01 1972-11-17 Orsymonde 1-(3,5-dimethoxyphenoxy)-2-morpholinoethane - antitumour activity esp against melanomas
CH602581A5 (en:Method) * 1976-07-19 1978-07-31 Cermol Sa
US4795758A (en) * 1986-02-10 1989-01-03 Societe A Responsabilite Limitee: Institut De Recherches Chimiques Et Biologiques Appliquees (I.R.C.E.B.A.) 5-[2-(pyrrolidin-1-yl)ethoxy]-p-cymene derivatives, the process for the preparation of the said derivatives and drugs in which the said derivatives are present
DK368687A (da) * 1986-11-21 1988-05-22 Cheminova As Aminoalkylerede hydroxyforbindelser og deres anvendelse som fungicider
EP1545519B1 (en) 2002-08-19 2011-03-23 Pfizer Inc. Combination therapy for hyperproliferative diseases
JP4799872B2 (ja) * 2004-03-31 2011-10-26 株式会社アクティバスファーマ 4級アンモニウム化合物、その製造方法及び脳血管障害治療剤
TWI356054B (en) * 2004-03-31 2012-01-11 Activus Pharma Co Ltd Quaternary ammonium compound, producing method the
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
JP2006193494A (ja) * 2005-01-17 2006-07-27 Dainippon Ink & Chem Inc 4級アンモニウム系化合物を有効成分とする心臓疾患治療剤
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
JP5498168B2 (ja) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー アテローム性動脈硬化および循環器疾患の治療のためのcetp阻害剤としてのn−((3−ベンジル)−2,2−(ビス−フェニル)−プロパン−1−アミン誘導体
SG11201507496UA (en) 2013-04-17 2015-11-27 Pfizer N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
US11248001B2 (en) 2019-01-18 2022-02-15 Astrazeneca Ab PCSK9 inhibitors and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE727243A (en:Method) * 1969-01-22 1969-07-01

Also Published As

Publication number Publication date
JPS5136256B1 (en:Method) 1976-10-07
NL166937C (nl) 1981-10-15
CH508585A (fr) 1971-06-15
DE2020464A1 (de) 1970-11-12
FR2042382A1 (en:Method) 1971-02-12
GB1262785A (en) 1972-02-09
BE749079A (fr) 1970-10-01
NL166937B (nl) 1981-05-15
FR2042382B1 (en:Method) 1974-05-24
US3740397A (en) 1973-06-19

Similar Documents

Publication Publication Date Title
AU2270770A (en:Method)
CS153565B2 (en:Method)
AU465452B2 (en:Method)
FR2042382B1 (en:Method)
CS154010B1 (en:Method)
AU429630B2 (en:Method)
AU5712069A (en:Method)
CS151054B2 (en:Method)
AU5113869A (en:Method)
AT308690B (en:Method)
AU438128B2 (en:Method)
AU470661B1 (en:Method)
AU417208B2 (en:Method)
AU442322B2 (en:Method)
AU442285B2 (en:Method)
AU442380B2 (en:Method)
AU425297B2 (en:Method)
AU442357B2 (en:Method)
AU428074B2 (en:Method)
AU6261969A (en:Method)
AU5079269A (en:Method)
AU5988769A (en:Method)
AU4923469A (en:Method)
AU5228269A (en:Method)
AU6144869A (en:Method)

Legal Events

Date Code Title Description
V4 Discontinued because of reaching the maximum lifetime of a patent